-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Ultragenyx Pharmaceutical, Raises Price Target to $19

Benzinga·11/04/2026 19:39:35
Listen to the news
TD Cowen analyst Yaron Werber maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price target from $18 to $19.